A detailed history of Flagship Harbor Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 2,136 shares of AMGN stock, worth $629,116. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,136
Previous 2,186 2.29%
Holding current value
$629,116
Previous $621,000 10.79%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$309.38 - $337.38 $15,469 - $16,869
-50 Reduced 2.29%
2,136 $688,000
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $77,972 - $94,122
-290 Reduced 11.71%
2,186 $621,000
Q4 2023

Jan 10, 2024

BUY
$255.7 - $288.46 $128,872 - $145,383
504 Added 25.56%
2,476 $713,000
Q3 2023

Oct 17, 2023

SELL
$218.65 - $271.46 $13,119 - $16,287
-60 Reduced 2.95%
1,972 $529,000
Q2 2023

Jul 11, 2023

SELL
$214.27 - $253.37 $127,276 - $150,501
-594 Reduced 22.62%
2,032 $451,000
Q1 2023

Apr 12, 2023

BUY
$225.79 - $275.2 $148,795 - $181,356
659 Added 33.5%
2,626 $634,000
Q4 2022

Jan 13, 2023

BUY
$229.03 - $291.01 $3,435 - $4,365
15 Added 0.77%
1,967 $0
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $7,856 - $8,860
-35 Reduced 1.76%
1,952 $440,000
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $148,577 - $165,340
-644 Reduced 24.48%
1,987 $483,000
Q1 2022

Apr 13, 2022

SELL
$219.27 - $242.57 $46,046 - $50,939
-210 Reduced 7.39%
2,631 $636,000
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $135,039 - $154,540
679 Added 31.41%
2,841 $639,000
Q2 2021

Jul 26, 2021

SELL
$233.58 - $259.14 $28,496 - $31,615
-122 Reduced 5.34%
2,162 $527,000
Q1 2021

May 03, 2021

BUY
$221.91 - $258.6 $1,997 - $2,327
9 Added 0.4%
2,284 $568,000
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $143,459 - $170,835
663 Added 41.13%
2,275 $523,000
Q3 2020

Oct 13, 2020

SELL
$234.65 - $260.95 $36,370 - $40,447
-155 Reduced 8.77%
1,612 $409,000
Q2 2020

Jul 31, 2020

BUY
$197.81 - $242.74 $89,607 - $109,961
453 Added 34.47%
1,767 $416,000
Q1 2020

May 12, 2020

BUY
$182.24 - $241.7 $4,373 - $5,800
24 Added 1.86%
1,314 $266,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $29,138 - $37,452
-154 Reduced 10.66%
1,290 $311,000
Q3 2019

Oct 22, 2019

BUY
$174.11 - $208.62 $29,946 - $35,882
172 Added 13.52%
1,444 $279,000
Q2 2019

Jul 22, 2019

BUY
$166.7 - $195.41 $34,173 - $40,059
205 Added 19.21%
1,272 $234,000
Q1 2019

Apr 15, 2019

SELL
$180.87 - $203.88 $904 - $1,019
-5 Reduced 0.47%
1,067 $202,000
Q4 2018

Jan 28, 2019

SELL
$178.4 - $208.25 $84,740 - $98,918
-475 Reduced 30.7%
1,072 $208,000
Q3 2018

Nov 05, 2018

BUY
$185.29 - $208.89 $9,079 - $10,235
49 Added 3.27%
1,547 $320,000
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $248,742 - $279,391
1,498 New
1,498 $276,000
Q1 2018

Apr 24, 2018

SELL
$169.43 - $198.0 $227,544 - $265,914
-1,343 Closed
0 $0
Q4 2017

Jan 24, 2018

BUY
$168.79 - $188.59 $1,687 - $1,885
10 Added 0.75%
1,343 $243,000
Q3 2017

Oct 23, 2017

SELL
$167.29 - $191.0 $19,238 - $21,965
-115 Reduced 7.94%
1,333 $250,000
Q2 2017

Aug 09, 2017

BUY
N/A
1,448
1,448 $249,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.